Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: A meta-analysis of 26 studies

Molecular Biology Reports

Volumn 38, Issue 4, 2011, Pages 2491-2497

  Zhang, Ronggui ^a   Xu, Guangyong ^a   Chen, Wenjun ^a   Zhang, Weili ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Gene polymorphism; Glutathione S transferase M1; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE;

ARTICLE; ASIAN; BLADDER CANCER; CANCER GRADING; CANCER RISK; CANCER STAGING; CAUCASIAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; OUTCOMES RESEARCH; RACE DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; BLADDER TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; NEGRO; RISK;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 79960953434     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0386-6     Document Type: Article

References (61)

1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
2. Zeegers MP, Tan FE, Dorant E et al (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630-639
3. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239-249
4. Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a metaanalysis. Clin Exp Med 10:59-68
5. Kellen E, Hemelt M, Broberg K et al (2007) Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 165:1221-1230
6. Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335-1340
7. Liu D, Liao M, Zuo J et al (2001) The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation. Mol Biol Rep 28:19-25
8. Zendeh-Boodi Z, Saadat M (2008) Genetic polymorphism of GSTT1 may be under natural selection in a population chronically exposed to natural sour gas. Mol Biol Rep 35:673-676
9. Saadat M (2009) Serum levels of testosterone and gonadotrophins with respect to smoking status and genetic polymorphism of GSTT1. Mol Biol Rep 36:1353-1356
10. Tang JJ, Wang MW, Jia EZ et al (2010) The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol Biol Rep 37:405-410
11. Azarpira N, Nikeghbalian S, Geramizadeh B et al (2010) Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol Biol Rep 37:21-25
12. Rafiee L, Saadat I, Saadat M (2010) Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 37:155-158
13. Saadat I, Saadat M (2010) Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep 37:249-253
14. Masoudi M, Saadat I, Omidvari S et al (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36:781-784
15. Ye Z, Parry JM (2003) A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9:SR83-SR91
16. Altinisik J, Balta ZB, Aydin G et al (2010) Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep 37:263-267
17. Sull JW, Ohrr H, Kang DR et al (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 45:683-689
18. Tripathy CB, Roy N (2006) Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28:217-224
19. Engel LS, Taioli E, Pfeiffer R et al (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156:95-109
20. Egger M, Davey Smith G, Schneider M et al (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634
21. Begg CB, Mazumdar M(1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
22. Harries LW, Stubbins MJ, Forman D et al (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644
23. Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729-734
24. Cao W, Cai L, Rao JY et al (2005) Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104:2400-2408
25. Mittal RD, Srivastava DS AM et al (2005) Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 6:6-9
26. Kopps S, Angeli-Greaves M, Blaszkewicz M et al (2008) Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J Toxicol Environ Health A 71:898-901
27. Okkels H, Sigsgaard T, Wolf H et al (1997) Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6:225-231
28. Martone T, Vineis P, Malaveille C et al (2000) Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 462: 303-309
29. Kellen E, Zeegers M, Paulussen A et al (2007) Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett 245:51-60
30. Rioja Zuazu J, Bandres Elizalde E, Rosell Costa D et al (2007) Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors. Actas Urol Esp 31:1107-1116
31. Srivastava DS, Kumar A, Mittal B et al (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430-434
32. Abd El Hameed AH, Negm OE, El-Gamal OM et al (2008) Genetic polymorphism of glutathione S-transferases M1 and T1 in Egyptian patients with bilharzial bladder cancer. Urol Oncol: doi:10.1016/j.urolonc.2008.1009.1015
33. Zhong S, Wyllie AH, Barnes D et al (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824
34. Anwar WA, Abdel-Rahman SZ, El-Zein RA et al (1996) Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923-1929
35. Brockmoller J, Cascorbi I, Kerb R et al (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915-3925
36. Kim WJ, Lee HL, Lee SC et al (2000) Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164:209-213
37. Aktas D, Ozen H, Atsu N et al (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. A marker for invasive bladder cancer? Cancer Genet Cytogenet 125:1-4
38. Toruner GA, Akyerli C, Ucar A et al (2001) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75:459-464
39. Ma QW, Lin GF, Chen JG et al (2002) Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 15:253-260
40. Jong Jeong H, Jin Kim H, Young Seo I et al (2003) Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 202:193-199
41. Hung RJ, Boffetta P, Brennan P et al (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598-604
42. Moore LE, Wiencke JK, Bates MN et al (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer casecontrol study in Argentina. Cancer Lett 211:199-207
43. Saad AA, O'Connor PJ, Mostafa MH et al (2005) Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers 20:69-72
44. Sobti RC, Al-Badran AI, Sharma S et al (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68-73
45. Srivastava DS, Mishra DK, Mandhani A et al (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48:339-344
46. McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239
47. Cengiz M, Ozaydin A, Ozkilic AC et al (2007) The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol 39:1043-1048
48. Moore LE, Malats N, Rothman N et al (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452-2458
49. Murta-Nascimento C, Silverman DT, Kogevinas M et al (2007) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 16:1595-1600
50. Zhao H, Lin J, Grossman HB et al (2007) Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 120:2208-2213
51. Covolo L, Placidi D, Gelatti U et al (2008) Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol 23:355-362
52. Altayli E, Gunes S, Yilmaz AF et al (2009) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41: 259-266
53. Grando JP, Kuasne H, Losi-Guembarovski R et al (2009) Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med 9:21-28
54. Rouissi K, Ouerhani S, Marrakchi R et al (2009) Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet 190: 101-107
55. Song DK, Xing DL, Zhang LR et al (2009) Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32:416-423
56. Zupa A, Sgambato A, Bianchino G et al (2009) GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Res 29:1709-1714
57. Ioannidis JP, Boffetta P, Little J et al (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37:120-132
58. Carlsten C, Sagoo GS, Frodsham AJ et al (2008) Glutathione Stransferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759-774
59. La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53-60
60. Karagas MR, Park S, Warren A et al (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63-69
61. Cantor KP, Lynch CF, Hildesheim ME et al (1998) Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 9:21-28